Bayesian multi-view models for data-driven drug response analysis

A central challenge faced by biological and medical research is to understand the impact of chemical entities on living cells. Identifying the relationships between the chemical structures and their cellular responses is valuable for improving drug design and targeted therapies. The chemical structures and their detailed molecular responses need to be combined through a systematic analysis to learn the complex dependencies, which can then assist in improving understanding of the molecular mechanisms of drugs as well as predictions on the effects of unknown molecules. Moreover, with emerging drug-response data sets being profiled over several disease types and phenotypic details, it is pertinent to develop advanced computational methods that can be used to study multiple sets of data together. In this thesis, a novel multi-disciplinary challenge is undertaken for computationally analyzing interactions between multiple biological responses and chemical properties of drugs, while simultaneously advancing the computational methods to better learn these interactions. Specifically, multi-view dependency modeling of paired data sets is formulated as a means of systematically studying the drug-response relationships. First, the systematic analysis of drug structures and their genome-wide responses is presented as a multi-set dependency modeling problem and established methods are adopted to test the novel hypothesis. Several novel extensions of the drug-response analysis are then presented that explore responses measured over multiple disease types and multiple levels of phenotypic detail, uncovering novel biological insights of potential impact. These analyses are made possible by novel advancements in multi-view methods. Specifically, the first Bayesian tensor canonical correlation analysis and its extensions are introduced to capture the underlying multi-way structure and applied in analyzing novel toxicogenomic interactions. The results illustrate that modeling the precise multi-view and multi-way formulation of the data is valuable for discovering interpretable latent components as well as for the prediction of unseen responses of drugs. Therefore, the original contribution to knowledge in this dissertation is two-fold: first, the data-driven identification of relationships between structural properties of drugs and their genome-wide responses in cells and, second, novel advancements of multi-view methods that find dependencies between paired data sets. Open source implementations of the new methods have been released to facilitate further research

On some properties of ideal convergent double sequences in fuzzy normed spaces

Recently, Rashid et al. [Rashid, Mohammad HM and Kočinac, Ljubiša DR. Ideal convergence in 2–fuzzy 2–normed spaces, Hacettepe Journal of Mathematics and Statistics, 46(1):149–162, 2017] defined the notion of ideal convergence of single sequences in 2–fuzzy 2–normed linear spaces. The aim of this paper is to generalize this notion to the double sequences in such spaces. For the sake of generalizing we define some concepts that contribute basically to outcomes that we came up with and study some basic properties of these new definitions.Publisher's Versio

Effect of machining parameters on surface roughness during wet and dry Wire-EDM of stainless steel

Surface integrity of Machined parts is one of the major machining characteristics that play an important role in determining the quality of engineering components. It is well-known fact that good quality surfaces improve the fatigue strength, corrosion and wear resistance of workpiece. The purpose of this study was to investigate the effects of Wire-Electrical Discharge Machining (WEDM) variables on surface topography of stainless steel. In the present work, the effects of pulse current and gap voltage on surface topography during wet and dry WEDM of stainless steel were investigated. It was evident that as the two process parameters increase the surface topography of workpiece becomes worse. The effect of both dry and wet machining conditions on surface topography is also reported in this paper

Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach

Motivation: Proteomics profiling is increasingly being used for molecular stratification of cancer patients and cell-line panels. However, systematic assessment of the predictive power of large-scale proteomic technologies across various drug classes and cancer types is currently lacking. To that end, we carried out the first pan-cancer, multi-omics comparative analysis of the relative performance of two proteomic technologies, targeted reverse phase protein array (RPPA) and global mass spectrometry (MS), in terms of their accuracy for predicting the sensitivity of cancer cells to both cytotoxic chemotherapeutics and molecularly targeted anticancer compounds.Results: Our results in two cell-line panels demonstrate how MS profiling improves drug response predictions beyond that of the RPPA or the other omics profiles when used alone. However, frequent missing MS data values complicate its use in predictive modeling and required additional filtering, such as focusing on completely measured or known oncoproteins, to obtain maximal predictive performance. Rather strikingly, the two proteomics profiles provided complementary predictive signal both for the cytotoxic and targeted compounds. Further, information about the cellular-abundance of primary target proteins was found critical for predicting the response of targeted compounds, although the non-target features also contributed significantly to the predictive power. The clinical relevance of the selected protein markers was confirmed in cancer patient data. These results provide novel insights into the relative performance and optimal use of the widely applied proteomic technologies, MS and RPPA, which should prove useful in translational applications, such as defining the best combination of omics technologies and marker panels for understanding and predicting drug sensitivities in cancer patients

Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugs

Peer reviewe

Drug Target Commons : A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions

Knowledge of the full target space of bioactive substances, approved and investigational drugs as well as chemical probes, provides important insights into therapeutic potential and possible adverse effects. The existing compound-target bioactivity data resources are often incomparable due to non-standardized and heterogeneous assay types and variability in endpoint measurements. To extract higher value from the existing and future compound target-profiling data, we implemented an open-data web platform, named Drug Target Commons (DTC), which features tools for crowd-sourced compound-target bioactivity data annotation, standardization, curation, and intra-resource integration. We demonstrate the unique value of DTC with several examples related to both drug discovery and drug repurposing applications and invite researchers to join this community effort to increase the reuse and extension of compound bioactivity data.Peer reviewe

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Research priorities to reduce the impact of COVID-19 in low- and middle-income countries

publishedVersio